Mar 17, 2026 08:02AM
Dec 3, 2025 09:00AM
Dec 3, 2025 09:00AM
Nov 13, 2025 09:00AM
Sep 2, 2025 09:00AM
Jun 16, 2025 08:02AM
Jun 16, 2025 08:00AM Windtree Announces Publication of Istaroxime Positive Phase 2 SEISMiC B Study
Jun 11, 2025 09:01AM
Jun 11, 2025 09:00AM
Jun 10, 2025 08:01AM
Jun 10, 2025 08:00AM
Jun 9, 2025 08:15AM
Jun 9, 2025 08:15AM
Jun 3, 2025 04:07PM Windtree Therapeutics (WINT) Announces Plan for Cryptocurrency Treasury Policy
Jun 3, 2025 04:05PM
May 22, 2025 08:16AM
May 19, 2025 08:00AM
May 16, 2025 08:00AM
May 12, 2025 08:00AM
May 6, 2025 08:19AM
May 6, 2025 08:18AM Windtree Announces Istaroxime Exclusivity and Intellectual Property Potential Strategy for US
May 1, 2025 08:30AM
Apr 15, 2025 08:00AM
Mar 26, 2025 08:47AM
Mar 24, 2025 08:30AM
Mar 24, 2025 08:01AM
Mar 24, 2025 08:00AM
Mar 20, 2025 08:02AM Windtree Therapeutics, Inc. (WINT) Announces License and Supply Agreement to Become Sourcing Partner for a Small Biotech with an FDA Approved Product
Mar 20, 2025 08:00AM
Mar 4, 2025 08:03AM
Mar 4, 2025 08:00AM
Feb 27, 2025 08:00AM
Feb 18, 2025 08:01AM
Feb 18, 2025 08:00AM
Feb 12, 2025 08:05AM Windtree Therapeutics (WINT) Announces Special Late-Breaking Clinical Science Abstract Presentation on Istaroxime at the Technology and Heart Failure Therapeutics Conference
Feb 12, 2025 08:00AM
Jan 15, 2025 08:00AM
Jan 13, 2025 08:01AM
Jan 13, 2025 08:00AM
Jan 8, 2025 08:01AM
Jan 8, 2025 08:00AM
Dec 16, 2024 08:00AM Windtree Announces Istaroxime Presentation By Cardiogenic Shock Thought Leader At Cardiovascular Clinical Trials Conference
Dec 9, 2024 08:00AM
Dec 4, 2024 08:00AM
Nov 27, 2024 04:05PM
Nov 14, 2024 08:00AM
Nov 14, 2024 08:00AM
Nov 4, 2024 08:00AM
Oct 30, 2024 08:00AM Windtree Therapeutics Initiates SEISMiC C Study of Istaroxime in SCAI Stage C Cardiogenic Shock for Planned Completion of Phase 2b and Transition to Phase 3
Oct 23, 2024 08:05AM

1,157,766 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All